About DAB
DAB is a company based in Delft (Netherlands) founded in 2012 by Sef Heijnen. DAB has raised $2.23 million across 2 funding rounds from investors including InnovationQuarter, FORWARD.one and Navus Ventures. DAB operates in a competitive market with competitors including Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
- Headquarter Delft, Netherlands
- Founders Sef Heijnen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.23 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
InnovationQuarter
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DAB
Unlock access to complete
Unlock access to complete
Funding Insights of DAB
DAB has successfully raised a total of $2.23M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DAB
DAB has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include InnovationQuarter, FORWARD.one and Navus Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic VC firm investing primarily in the Netherlands
|
Locked | Locked | Locked | |
|
Venture capital investments are made in early-stage European tech startups.
|
Locked | Locked | Locked | |
|
High-tech startups are funded across early and growth stages.
|
Locked | Locked | Locked |
Investor details for DAB
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DAB
Investment portfolio details for DAB
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DAB
Detailed financials for DAB
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dab Comparisons
Peer comparison for DAB
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DAB
DAB operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unibio, Univercells Tech, Nirrin Technologies, Pow.Bio and Caladan Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Animal feed supplements are produced using proprietary fermentation technology.
|
|
| Locked | Locked | Locked |
Intensified biomanufacturing technologies for viral production are developed and manufactured.
|
|
| Locked | Locked | Locked |
Developer of sensor and integration technologies for continuous control and bioprocess automation
|
|
| Locked | Locked | Locked |
Intelligent fermentation services for industrial and synthetic biology are provided.
|
|
| Locked | Locked | Locked |
Modular bioreactors are developed for biotechnology research applications.
|
|
| Locked | Locked | Locked |
Customized bioprocess equipment and automation solutions are provided for biopharmaceuticals.
|
Detailed competitors of DAB
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dab
Complete news archive for DAB
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DAB
DAB was founded in 2012 and raised its 1st funding round 7 years after it was founded.
DAB is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Kirsten Herben Steinbusch is the current CEO of DAB.
DAB is a funded company, having raised a total of $2.23M across 2 funding rounds to date.
DAB was founded in 2012 in Delft, Netherlands, as a provider of technology solutions in the biotechnology sector. Accelerated fermentation processes are enabled to produce chemicals, materials, and fuels from renewable feedstocks. Solutions are also offered for fermentations involving water-insoluble products. Operations focus on industrial applications within sustainable manufacturing.
DAB's top competitors include Unibio, Univercells Tech and Nirrin Technologies.
DAB has 4 investors. Key investors include InnovationQuarter, FORWARD.one, Navus Ventures, and Capricorn Partners.